| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Disease Antibodies (IgG, IgM), Immunoblot (LYMWB)
Test CodeLAB787
Quest Code
8593
CPT Codes
86617 (x2)
Preferred Specimen
1 mL serum in gold top or plain red top tube
Minimum Volume
0.5 mL
Instructions
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic
Methodology
Immunoblot (IB)
Setup Schedule
Set up 7: 00 AM expected release time 5: 00 PM. Monday through friday (apr. Through sept. ) tuesday and thursday (oct. Through march)
Report Available
3 days
Reference Range
| Lyme Disease Ab (IgG), Blot | Negative |
| Lyme Disease Ab (IgM), Blot | Negative |
Clinical Significance
Lyme disease is transmitted by a tick vector carrying Borrelia burgdorferi. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA or IFA test result.
Performing Laboratory
| Quest Diagnostics - South Region |
